vs
SOLAI Ltd（SLAI）与Verastem, Inc.（VSTM）财务数据对比。点击上方公司名可切换其他公司
Verastem, Inc.的季度营收约是SOLAI Ltd的1.0倍（$11.2M vs $11.0M），SOLAI Ltd净利率更高（-126.2% vs -876.3%，领先750.1%）
Verastem, Inc.以Verastem Oncology品牌开展业务，是一家总部位于美国马萨诸塞州波士顿的制药企业，专注于开发抗癌治疗药物，该公司成立于波士顿，同时是纳斯达克生物技术指数成分股之一。
SLAI vs VSTM — 直观对比
营收规模更大
VSTM
是对方的1.0倍
$11.0M
净利率更高
SLAI
高出750.1%
-876.3%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $11.2M |
| 净利润 | $-13.9M | $-98.5M |
| 毛利率 | 0.1% | — |
| 营业利润率 | -126.2% | -362.2% |
| 净利率 | -126.2% | -876.3% |
| 营收同比 | -43.1% | — |
| 净利润同比 | -173.4% | -311.1% |
| 每股收益（稀释后） | $-0.01 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLAIVSTM
| Q3 25 | — | $11.2M | ||
| Q2 25 | $11.0M | $2.1M | ||
| Q3 24 | — | $0 | ||
| Q2 24 | $19.4M | $10.0M |
净利润SLAIVSTM
| Q3 25 | — | $-98.5M | ||
| Q2 25 | $-13.9M | $-25.9M | ||
| Q3 24 | — | $-24.0M | ||
| Q2 24 | $18.9M | $-8.3M |
毛利率SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 52.4% | — |
营业利润率SLAIVSTM
| Q3 25 | — | -362.2% | ||
| Q2 25 | -126.2% | -2047.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.6% | -182.8% |
净利率SLAIVSTM
| Q3 25 | — | -876.3% | ||
| Q2 25 | -126.2% | -1213.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | 97.9% | -82.6% |
每股收益（稀释后）SLAIVSTM
| Q3 25 | — | $-1.35 | ||
| Q2 25 | $-0.01 | $-0.62 | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | $0.02 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $137.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $43.8M | $-15.5M |
| 总资产 | $69.1M | $176.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SLAIVSTM
| Q3 25 | — | $137.7M | ||
| Q2 25 | $1.2M | $164.3M | ||
| Q3 24 | — | $113.2M | ||
| Q2 24 | $2.3M | $83.4M |
总债务SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | $40.5M | ||
| Q2 24 | — | $40.3M |
股东权益SLAIVSTM
| Q3 25 | — | $-15.5M | ||
| Q2 25 | $43.8M | $36.1M | ||
| Q3 24 | — | $11.1M | ||
| Q2 24 | $45.9M | $18.9M |
总资产SLAIVSTM
| Q3 25 | — | $176.9M | ||
| Q2 25 | $69.1M | $196.3M | ||
| Q3 24 | — | $126.4M | ||
| Q2 24 | $63.3M | $105.7M |
负债/权益比SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | 3.66× | ||
| Q2 24 | — | 2.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.0M | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | $-17.0M | — |
| 自由现金流率自由现金流/营收 | -154.2% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SLAIVSTM
| Q3 25 | — | $-36.2M | ||
| Q2 25 | $-17.0M | $-32.7M | ||
| Q3 24 | — | $-23.8M | ||
| Q2 24 | $-12.1M | $-27.6M |
自由现金流SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | $-17.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-27.6M |
自由现金流率SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | -154.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -275.8% |
资本支出强度SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% |
现金转化率SLAIVSTM
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLAI
| Data center | $6.5M | 59% |
| Cryptocurrency mining | $4.6M | 41% |
VSTM
暂无分部数据
